Provision of Services for the Conduct of Genomic Testing for Medical Oncology in the Year 2025

This tender involves the provision of services for conducting genomic testing specifically for medical oncology during the year 2025. The primary objective is to enhance cancer treatment and research through advanced genomic analysis. Key requirements for bidders include demonstrated expertise in genomic testing, compliance with relevant medical standards, and the ability to deliver timely results. The successful contractor will be expected to collaborate closely with healthcare providers to ensure that the testing meets the specific needs of oncology patients. This initiative is aimed at improving patient outcomes by utilizing cutting-edge genomic technologies. The location for the services will primarily be within healthcare facilities designated for oncology treatment. Bidders must also provide evidence of previous experience in similar projects and the capacity to handle the expected volume of tests. The tender is open to qualified organizations that can meet the outlined criteria and contribute to the advancement of medical oncology through innovative genomic solutions.

This is a services contract in the health and medical services and Research sectors, with a focus on Medical Equipment. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 37,485.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.